Skip to content

Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia

Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia: a Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07028190
Enrollment
840
Registered
2025-06-19
Start date
2025-06-12
Completion date
2027-03-31
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive Endoscopy, Insomnia

Keywords

Insomnia, Digestive endoscopy, Rimazolen

Brief summary

To compare the dosage requirement of rimazolen under intravenous anesthesia between patients with insomnia and those with normal sleep pattern.

Detailed description

The investigators aim to investigate whether rimazolen dosage requirement is increased in patients with insomnia under intravenous anesthesia compared with normal sleep patterns.

Interventions

No interventions, this study is to compare the dosage requirement of ciprofol under intravenous anesthesia between insomnia group and normal sleep group.

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER
Daxing Teaching Hospital, Capital Medical University
CollaboratorOTHER
Hebei Medical University Third Hospital
CollaboratorOTHER
Hengshui People's Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Patients with insomnia: 1. Age of 18 - 64 years; 2. American Society of Anesthesiologists (ASA) physical status of I - II; 3. Body mass index (BMI) of 15 - 30; 4. Patients undergoing elective thoracoscopy, laparoscopy, hysteroscopy, open abdominal surgery, open thoracic surgery, open spinal surgery, craniotomy surgery, and digestive endoscopy under general anesthesia; 5. Positive screening results according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for insomnia disorder; 6. 8-item Sleep Condition Indicator (SCI; score 0-4; range 0-32, higher score means better sleep) scored 16 or less. * Patients with normal sleep: 1. Age of 18 - 64 years; 2. ASA physical status of I - II; 3. BMI of 15 - 30; 4. Patients undergoing elective thoracoscopy, laparoscopy, hysteroscopy, open abdominal surgery, open thoracic surgery, open spinal surgery, craniotomy surgery, and digestive endoscopy under general anesthesia; 5. No history or evidence of insomnia.

Exclusion criteria

1. Associated with any neurological disease; 2. Daily alcohol consumption; 3. Any contraindication to intravenous anesthetic drug, such as hypotension or shock; 4. History of allergy to any drug used in the study; 5. Pregnancy or breastfeeding; 6. Patients with sleep apnea syndrome; 7. acute upper respiratory infection; 8. Patients with psychological diseases who report suicidal thoughts; 9. Patients who need to work or take care of children/elderly people frequently at night.

Design outcomes

Primary

MeasureTime frameDescription
The total consumption of rimazolenUp to 1 dayThe total consumption of rimazolen for the produre. It includes the total amount of ciprofol required by the patient for the entire procedure.

Secondary

MeasureTime frameDescription
The dosage of rimazolen for induction of anesthesia1 dayThe dosage of rimazolen for induction of anesthesia
The occurrence of the respiratory and cardiovascular adverse eventsThe day of the procedure and 24 hours after the procedureThe occurrence of the respiratory and cardiovascular adverse events such as hypoxemia, hypotension, hypertension, arrhythmia
The occurrence of the other adverse eventsThe day of the procedure and 24 hours after the procedureThe occurrence of the other adverse events such as dizziness, agitation, nausea, vomiting and psychiatric symptom
The incidence of intraoperative recall or awarenessThe day of the procedure and 24 hours after the procedureThe patient is conscious after anesthesia
The recovery timeUp to 1 dayThe time from when the patient stops intravenous anesthetic drug application to when they can open their eyes and nod their heads.
Duration of patients' PACU stayUp to 1 dayPatients' stay time in PACU
The ease of operation at this level of sedation evaluated by the operation doctorsUp to 1 dayThe ease of operation at this level of sedation (easy/medium/difficult) evaluated by the operation doctors
The satisfaction degree of anesthesia effect evaluated by the operation doctorsUp to 1 dayThe satisfaction degree of anesthesia effect (satisfactory/medium/unsatisfactory) evaluated by the operation doctors
Patients' satisfactionUp to 1 dayPatients' satisfaction with the procedure at this level of sedation (satisfactory/medium/unsatisfactory)
Patients' willingnessUp to 1 dayPatients' willingness to undergo the next procedure at the same level of sedation. Patient willingness is divided into three levels: willing, moderate, and unwilling.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026